How have the shares performed?
Outset Medical Inc. (OM) saw an uptrend of 3.63% in the recent trading with $46.55 being its most recent. The current price level -30.48% lower than the highest price of $66.96 marked by the stock while trading over the past 52-weeks, whereas it is 13.34% higher than the lowest price of $41.07 the company dropped to over past 52-weeks. The latest news story on OM appeared in Business Wire under the title “Satellite Healthcare and Outset Medical Announce Multi-Year Agreement to Increase Home Dialysis Penetration” on Jun-02-21.
Squeezing the time span to 30 day period shows us the stock is currently trading -11.10% below one month high and is +13.34% above of the lowest during that time. Looking into the simple moving average, Outset Medical Inc. (OM)’s stock stands at a SMA-50 of $51.38 while that of 5-day is reading $45.60.
Do analysts rate it as a buy, sell or hold?
Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Currently, the stock has been recommended as Strong Buy by 7 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.90 for the stock.
Outset Medical Inc. Earnings – What Happened With OM
Coming around sales and income figures, publically trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor. Outset Medical Inc. (OM) last released financial results for the quarter that ended 3/30/2021, posting a surprise factor of 13.60% for net revenue. During the reported three-month period, company’s sales were $22.92 billion while analysts on average were estimating the same to be $23.26 million.
OM – Outset Medical Inc. Stock Earnings Estimates
The perspective of Outset Medical Inc. (NASDAQ:OM)’s current quarter earnings identifies that analysts are in consensus over the estimate of -0.81 for stock’s EPS in the current quarter. 5 analysts covering the stock at Wall Street were agreed upon that EPS consensus. Company’s EPS for the last quarter was -0.7.
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 42.76 million. OM does have institutional investors; and they hold 90.50% of the stock.
Outset Medical Inc. – Insider Activity and Holdings
Moreover, the latest SEC filings also revealed that stock came across 31 new insider purchases involving 339,857 shares. On the other hand, OM declared 9,084,475 shares have been sold in 35 insider transactions over the past three months.
As on Mar 30, 2021, FMR, LLC was the top most holder in Outset Medical Inc. (NASDAQ:OM) with an ownership of 6.42 million shares of the company or 13.96% of the stake worth $349.23 million. The filing also reveals Warburg Pincus LLC as the second largest holder in the company with a control over 10.29% of the outstanding shares. Its stake is worth $257.38 million for having 4.73 million shares in hand.
Price (T.Rowe) Associates Inc also came holding a key position in the company during the recent quarter and it now holds 10.22% of the outstanding shares. With this there are now 155 institutions which have possession in OM’s shares.
Currently, the stock has been recommended as Strong Buy by 7 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.90 for the stock.
The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, current ratio recorded by Outset Medical Inc. was 9.43 while posting a debt to equity ratio of 0.00. The count was 11.48 for long-term debt to equity ratio.
Outset Medical Inc.’s return on equity, or ROE, is -68.80%, compared to the industry average of -0.14% for Healthcare – Medical Devices. Although this indicates that OM fails to use its equity well, the metric will vary significantly depending on the industry.